$NVCR NovoCure Ltd Insider Trading Week 35/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd in week 35/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 04 2020 | NVCR | NovoCure Ltd | Leonard Frank X | Chief Development O ... | Option Exercise | A | 84.68 | 11,336 | 959,932 | 11,336 | |
| Sep 04 2020 | NVCR | NovoCure Ltd | Leonard Frank X | Chief Development O ... | Grant | A | 0.00 | 5,904 | 0 | 81,633 | 75.7 K to 81.6 K (+7.80 %) |
| Sep 04 2020 | NVCR | NovoCure Ltd | Cordova Ashley | Chief Financial Off ... | Option Exercise | A | 84.68 | 11,336 | 959,932 | 11,336 | |
| Sep 04 2020 | NVCR | NovoCure Ltd | Cordova Ashley | Chief Financial Off ... | Grant | A | 0.00 | 5,904 | 0 | 26,442 | 20.5 K to 26.4 K (+28.75 %) |
| Sep 04 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 100 | 703 | 9,114 | |
| Sep 04 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 85.00 | 100 | 8,500 | 72,045 | 72.1 K to 72 K (-0.14 %) |
| Sep 04 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 100 | 703 | 72,145 | 72 K to 72.1 K (+0.14 %) |
| Sep 03 2020 | NVCR | NovoCure Ltd | Weinberg Uri | Chief Science Offic ... | Option Exercise | A | 84.68 | 3,779 | 320,006 | 3,779 | |
| Sep 03 2020 | NVCR | NovoCure Ltd | Weinberg Uri | Chief Science Offic ... | Grant | A | 0.00 | 1,968 | 0 | 27,597 | 25.6 K to 27.6 K (+7.68 %) |
| Sep 03 2020 | NVCR | NovoCure Ltd | Weinberg Uri | Chief Science Offic ... | Option Exercise | A | 84.68 | 3,779 | 320,006 | 3,779 | |
| Sep 03 2020 | NVCR | NovoCure Ltd | Weinberg Uri | Chief Science Offic ... | Grant | A | 0.00 | 1,968 | 0 | 27,597 | 25.6 K to 27.6 K (+7.68 %) |
| Sep 03 2020 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | A | 84.68 | 3,779 | 320,006 | 3,779 | |
| Sep 03 2020 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | P | 85.01 | 4,200 | 357,054 | 98,786 | 103 K to 98.8 K (-4.08 %) |
| Sep 03 2020 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Grant | A | 0.00 | 1,968 | 0 | 102,986 | 101 K to 103 K (+1.95 %) |
| Sep 03 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Option Exercise | A | 84.68 | 3,779 | 320,006 | 3,779 | |
| Sep 03 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Grant | A | 0.00 | 1,968 | 0 | 142,607 | 140.6 K to 142.6 K (+1.40 %) |